EAM Investors’s Ventyx Biosciences VTYX Stock Holding History

EAM Investors’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-111,398	Closed	-$1.01M	–	383
2025 Q4	$1.01M	Buy	+111,398	New	+$833K	0.11%	208
2023 Q2	–	Sell	-64,733	Closed	-$2.17M	–	380
2023 Q1	$2.17M	Sell	64,733 -194	-0.3%	-$7.54K	0.43%	86
2022 Q4	$2.13M	Sell	64,927 -18,311	-22%	-$542K	0.44%	79
2022 Q3	$2.91M	Buy	+83,238	New	+$1.84M	0.63%	34

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

EAM Investors's VTYX Position: Q1 2026 in Review

EAM Investors sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 111,398 shares — an estimated $1.01M sold.

EAM Investors first reported a position in VTYX in Q3 2022 and held it in 4 quarters. The position peaked at $2.91M in Q3 2022. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

EAM Investors reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
EAM Investors sold 111,398 Ventyx Biosciences shares in Q1 2026, an estimated $1.01M.
EAM Investors first reported a position in Ventyx Biosciences in Q3 2022 and held it in 4 quarters.
EAM Investors's Ventyx Biosciences position peaked at $2.91M in Q3 2022.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on EAM Investors's 13F filing for Q1 2026, filed 13 May 2026.